Showing 1 - 10 of 234
The contraction in health care consumption at the start of the pandemic provides insight into central economic questions of waste and productivity in the U.S. health care system. Using linked mortality and Electronic Medical Records, we compare people who had outpatient appointments scheduled...
Persistent link: https://www.econbiz.de/10013435115
We estimate the impact of increased access to telemedicine that followed widespread adoption during the March-April 2020 lockdown period in Israel (due to COVID-19). We focus on the post-lockdown period, which in Israel was characterized by a temporary return to normalcy. Prior to the lockdown,...
Persistent link: https://www.econbiz.de/10012599268
In February 2009 the U.S. Congress unexpectedly passed the Health Information Technology for Economic and Clinical Health Act (HITECH). HITECH provides up to $27 billion to promote adoption and appropriate use of Electronic Medical Records (EMR) by hospitals. We measure the extent to which...
Persistent link: https://www.econbiz.de/10012458112
Health information technology (IT) adoption, it is argued, will dramatically improve patient care. We study the impact of hospital IT adoption on patient outcomes focusing on the roles of technological and organizational complements in affecting IT's value and explore underlying mechanisms...
Persistent link: https://www.econbiz.de/10012459958
Persistent link: https://www.econbiz.de/10003212049
Persistent link: https://www.econbiz.de/10003681819
One explanation for insufficient use of primary care in the U.S. is a lack of trust between patients and providers - particularly along racial lines. We assess the role of racial concordance between patients and medical providers in driving use of preventive care and the implications for patient...
Persistent link: https://www.econbiz.de/10013477259
We study the effects of competition by state-owned firms, leveraging the decentralized entry of public pharmacies to local markets in Chile. Public pharmacies sell the same drugs at a third of private pharmacy prices, because of stronger upstream bargaining and market power in the private...
Persistent link: https://www.econbiz.de/10013477271
Difference-in-Difference (DID) estimators are a valuable method for identifying causal effects in the public health researcher's toolkit. A growing methods literature points out potential problems with DID estimators when treatment is staggered in adoption and varies with time. Despite this, no...
Persistent link: https://www.econbiz.de/10014436973
There is substantial evidence that cost-sharing in medical care constrains total health spending. However, there is relatively little (and unclear) evidence on its health effects, particularly in low- and middle-income countries. This paper re-evaluates the link between outpatient cost-sharing...
Persistent link: https://www.econbiz.de/10014437039